Sun Pharma & Samsung BioLogics announce strategic manufacturing tie-up for Tildrakizumab
Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab. The agreement was entered into by Sun Pharma's wholly-owned subsidiary and…
Read More...
Read More...